Spondyloarthritis & psoriatic arthritis
The ATTRACT study: screening for the early identification of axial psoriatic arthritis in a cohort of Italian psoriatic patients
Authors' conclusion
The DCS tool proved to be a valuable screening strategy for detecting and characterizing patients with axPsA in a real-life cohort of psoriasis patients in a dermatological setting and helped to identify a substantial number of patients affected by undiagnosed pPsA.
Study context
- Population
- Consecutive patients aged ≥18 years with a clinical diagnosis of psoriasis made by a dermatologist, Italy365 screened
- Participants
- 265 patients
- Outcome
- Diagnosis of axPsA among patients eligible for rheumatological referral by the dermatologist-centred screening (DCS) questionnaire
Methodological detailsscreening study, dermatology-based, consecutive patients
- Screening study
- Dermatology-based
- Consecutive patients
Main finding
As reported in the abstract
axPsA, with or without pPsA, among referred patients
Eligible for rheumatological referral
124 of 265
46.8%
Diagnosis of axial PsA (axPsA), with or without peripheral PsA (pPsA)
36 of 124
29.0%
Observational data: associations, not effects.
Further findings
pPsA without axial involvement
- pPsA without axial involvement
- 21/124 (16.9%)
Back pain at screening
- Back pain at screening
- 174 (66%)
- Back pain duration >3 months
- 158 (60%)
- Back pain onset before age 45 years
- 140 (53%)
Imaging in axPsA
- Active inflammatory and/or structural post-inflammatory changes in sacroiliac joints and/or spine observed in all axPsA patients
PsA vs psoriasis without PsA
- Numerically longer back pain duration and higher CRP levels in PsA vs psoriasis without PsA
Original publication
The ATTRACT study: screening for the early identification of axial psoriatic arthritis in a cohort of Italian psoriatic patients. Rheumatology (Oxford). Published 25 October 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →